PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers
NCT02039817
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Impairment
Renal Insufficiency
Kidney Disease
Kidney Diseases
Interventions
DRUG:
IDN-6556
Sponsor
Conatus Pharmaceuticals Inc.